A multinational healthcare company, Roche and a provider of digital integrated healthcare services, Oncopadi Technologies have launched a Breast Cancer Access Navigation and Testing Programme targeted ...

Canadian researchers have developed an effective new technique for identifying aggressive medulloblastoma—the most common ...

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with ...

Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...

The global tumor profiling market share analysis is on a strong growth trajectory, projected to reach USD 11.9 billion by 2025, with a CAGR of 8.3% from 2025 to 2035. This surge is fueled by the ...

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...

Five studies, including two oral presentations, demonstrate the critical role of Caris' comprehensive molecular profiling in ...

"DeepLIIF" algorithm enhances accuracy, reproducibility, and efficiency in pathology, providing a cost-effective solution for advanced biomarker analysis MONTVILLE, NJ / ACCESS Newswire / March 4, 202 ...

The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...

At K Hospital’s pathology center, doctors and technicians work tirelessly behind the scenes to provide accurate cancer diagnoses, ensuring precise treatment plans.

ABSTRACT: Background: Sentinel lymph node (SLN) biopsy remains a cornerstone in the management of breast cancer, as it provides an accurate staging of the disease while minimizing the morbidity ...